ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,511,002 | -45.1% | 195,599 | -37.9% | 0.12% | -36.5% |
| Q2 2023 | $6,394,319 | -39.2% | 314,836 | -45.4% | 0.20% | -38.4% |
| Q1 2023 | $10,519,884 | +23.9% | 576,748 | +40.5% | 0.32% | +23.1% |
| Q4 2022 | $8,488,726 | -5.5% | 410,480 | +19.6% | 0.26% | -11.3% |
| Q3 2022 | $8,982,000 | +41.6% | 343,335 | +37.1% | 0.29% | +35.0% |
| Q2 2022 | $6,345,000 | -11.1% | 250,385 | +10.8% | 0.22% | +22.6% |
| Q1 2022 | $7,134,000 | +28.3% | 226,050 | +64.5% | 0.18% | +55.3% |
| Q4 2021 | $5,560,000 | +52.1% | 137,387 | +31.0% | 0.11% | +65.2% |
| Q3 2021 | $3,656,000 | – | 104,848 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $42,172,000 | 23.15% |
| Octagon Capital Advisors LP | 2,668,316 | $69,803,000 | 12.05% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $22,754,000 | 8.25% |
| Finepoint Capital LP | 646,586 | $16,915,000 | 5.56% |
| PFM Health Sciences, LP | 3,383,233 | $88,505,000 | 3.20% |
| BVF INC/IL | 2,717,020 | $71,077,000 | 2.94% |
| Boxer Capital, LLC | 1,432,200 | $37,466,000 | 2.11% |
| DAFNA Capital Management LLC | 178,717 | $4,675,000 | 1.26% |
| SECTORAL ASSET MANAGEMENT INC | 227,032 | $5,939,000 | 1.17% |
| HighVista Strategies LLC | 71,650 | $1,874,000 | 1.07% |